![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 23, 2005.
Revised October 28, 2005.
Accepted for publication November 8, 2005.
9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors
Anandamide (AEA) and 
9-tetrahydrocannabinol (THC) are endogenous and exogenous ligands, respectively, for cannabinoid receptors. While most of the pharmacological actions of cannabinoids are mediated by CB1 receptors, there is also evidence that these compounds can produce effects that are not mediated by the activation of identified cannabinoid receptors. Here, we report that THC and AEA, in a CB1 receptor-independent manner, cause a significant potentiation of the amplitudes of glycine-activated currents (IGly) in acutely isolated neurons from rat ventral tegmental area (VTA) and in Xenopus oocytes expressing human homomeric (
1) and heteromeric (1
1) subunits of glycine receptors (GlyRs). The potentiation of IGly by THC and AEA is concentration-dependent with respective EC50 values of 86 ± 9 nM and 319 ± 31 nM for 1 homomeric receptors, 73 ± 8 nM and 318 ± 24 nM for 11 heteromeric receptors, and 115 ± 13 nM and 230 ± 29 nM for native GlyRs in VTA neurons. The effects of THC and AEA are selective for IGly, since GABA-activated current in VTA neurons or in Xenopus oocytes expressing 23
2 GABAA receptor subunits were unaffected by these compounds. The maximal potentiation by THC and AEA was observed at the lowest concentration of glycine; with increasing concentrations of glycine, the potentiation significantly decreased. The site for THC and AEA seems to be distinct from that of the alcohol and volatile anesthetics. The results indicate that THC and AEA, in pharmacologically relevant concentrations, directly potentiate the function of GlyRs through an allosteric mechanism.
Key words:
Cannabinoid, Glycine, Ion channel regulation, Func. analysis receptor/ion channel mutants, Alcohols
This article has been cited by other articles:
|
|
 |
|
  U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska Methanandamide Allosterically Inhibits in Vivo the Function of Peripheral Nicotinic Acetylcholine Receptors Containing the {alpha}7-Subunit J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 912 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xiong, M. Hosoi, B.-N. Koo, and L. Zhang Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization Mol. Pharmacol., February 1, 2008; 73(2): 314 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oz, K.-H. Yang, M. Dinc, and T. S. Shippenberg The Endogenous Cannabinoid Anandamide Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Xenopus Oocytes J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 547 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Spivak, C. R. Lupica, and M. Oz The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fisyunov, V. Tsintsadze, R. Min, N. Burnashev, and N. Lozovaya Cannabinoids Modulate the P-Type High-Voltage-Activated Calcium Currents in Purkinje Neurons J Neurophysiol, September 1, 2006; 96(3): 1267 - 1277. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
